| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0960-9822(07)00533-7 |
| P698 | PubMed publication ID | 9822576 |
| P2093 | author name string | Beug H | |
| Oft M | |||
| Heider KH | |||
| P2860 | cites work | p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest | Q24319021 |
| Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability | Q24319995 | ||
| TGF beta signals through a heteromeric protein kinase receptor complex | Q24337608 | ||
| CDC25 phosphatases as potential human oncogenes | Q28116546 | ||
| Lessons from hereditary colorectal cancer | Q28131788 | ||
| Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15 | Q28239045 | ||
| Mechanism of activation of the TGF-beta receptor | Q28245861 | ||
| Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells | Q28305879 | ||
| Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line | Q29547239 | ||
| Production of high-titer helper-free retroviruses by transient transfection | Q29547802 | ||
| Transforming growth factor β1 as a biomarker for prostate cancer | Q35190856 | ||
| Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro | Q35610349 | ||
| Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma | Q35979144 | ||
| Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation | Q36618743 | ||
| Transgenic models for the study of prostate cancer | Q40873364 | ||
| TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells | Q41164260 | ||
| Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase | Q41639273 | ||
| Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. | Q42771319 | ||
| Expression of mRNA for transforming growth factors-alpha and -beta and secretion of transforming growth factor-beta by renal cell carcinoma cell lines | Q43940493 | ||
| TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice | Q45345227 | ||
| Synergistic induction of mesoderm by FGF and TGF-beta and the identification of an mRNA coding for FGF in the early Xenopus embryo. | Q45989344 | ||
| Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. | Q47852627 | ||
| Absence of mutations in the transforming growth factor-beta type II receptor in sporadic lung cancers with microsatellite instability and rare H-ras1 alleles. | Q53442031 | ||
| Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. | Q53442180 | ||
| Analysis of the DPC4 gene in gastric carcinoma. | Q55001846 | ||
| MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma. | Q55410356 | ||
| Expression of transforming growth factor-beta 1 in prostate cancer. | Q64893650 | ||
| Somatic alterations of the DPC4 gene in human colorectal cancers in vivo | Q71739625 | ||
| Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta | Q71995235 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neoplastic invasiveness | Q112498967 |
| P304 | page(s) | 1243-1252 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Current Biology | Q1144851 |
| P1476 | title | TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis | |
| P478 | volume | 8 |
| Q52730282 | A Soft Microenvironment Protects from Failure of Midbody Abscission and Multinucleation Downstream of the EMT-Promoting Transcription Factor Snail. |
| Q37287606 | A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression |
| Q35193411 | A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras |
| Q35163454 | A role for LIM kinase in cancer invasion. |
| Q42526727 | A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells. |
| Q34768457 | A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. |
| Q38880519 | A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells |
| Q37209259 | Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer |
| Q35867458 | Abrogation of TGFbeta signaling induces apoptosis through the modulation of MAP kinase pathways in breast cancer cells |
| Q34238220 | Activation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor β2 in cancer cells |
| Q34928535 | Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro |
| Q83320051 | Alterations of Smad expression and activation in defining 2 subtypes of human head and neck squamous cell carcinoma |
| Q36994700 | An in vivo model of epithelial to mesenchymal transition reveals a mitogenic switch. |
| Q38075495 | Animal model for mammary tumor growth in the bone microenvironment |
| Q36039344 | Annexin A1 attenuates EMT and metastatic potential in breast cancer |
| Q22011170 | Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation |
| Q24545375 | Autocrine PDGFR signaling promotes mammary cancer metastasis |
| Q78392687 | Autocrine TGFbeta supports growth and survival of human breast cancer MDA-MB-231 cells |
| Q34972203 | BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression |
| Q38237390 | Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer |
| Q36670502 | Blockade of Autocrine TGF-β Signaling Inhibits Stem Cell Phenotype, Survival, and Metastasis of Murine Breast Cancer Cells |
| Q40858455 | Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas |
| Q34792468 | Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. |
| Q60912537 | CD44v6 engages in colorectal cancer progression |
| Q38983494 | CD63 tetraspanin is a negative driver of epithelial-to-mesenchymal transition in human melanoma cells |
| Q34275314 | CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer |
| Q35579295 | Cancer Invasion: Watch Your Neighbourhood! |
| Q35070726 | Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness |
| Q24610450 | Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis |
| Q40827270 | Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins |
| Q52545012 | Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. |
| Q46094678 | Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells |
| Q34373948 | Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo |
| Q37486150 | Correlation between the overexpression of epidermal growth factor receptor and mesenchymal makers in endometrial carcinoma |
| Q38610277 | Covalent Dimerization of Interleukin-Like Epithelial-to-Mesenchymal Transition (EMT) Inducer (ILEI) Facilitates EMT, Invasion and Late Aspects of Metastasis |
| Q36241249 | Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. |
| Q38265569 | Cytoskeleton targeting value in prostate cancer treatment |
| Q37687170 | Cytoskeleton-centric protein transportation by exosomes transforms tumor-favorable macrophages. |
| Q29616379 | Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer |
| Q26825789 | DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity |
| Q38968460 | Detection of binding of a synthetic granzyme B-like peptide fluorescent conjugate within platelet-like structures in cancer-related peripheral blood specimens and tissue sections |
| Q39027205 | Dichotomous roles of TGF-β in human cancer |
| Q73412891 | Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma |
| Q39441340 | Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis |
| Q33929011 | Disruption of TGF-beta growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization |
| Q44028985 | Distinct clinical features and outcomes of gastric cancers with microsatellite instability |
| Q33840435 | Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis |
| Q53376881 | Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. |
| Q39939616 | Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. |
| Q36866940 | Downregulation of MMP-2 and -9 by proteasome inhibition: a possible mechanism to decrease LEC migration and prevent posterior capsular opacification |
| Q34168587 | Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer |
| Q34292179 | Downregulation of transforming growth factor-β type II receptor prohibit epithelial-to-mesenchymal transition in lens epithelium |
| Q36052540 | E-cadherin is critical for collective sheet migration and is regulated by the chemokine CXCL12 protein during restitution |
| Q33301901 | EMT tumorigenesis in the mouse mammary gland |
| Q39517290 | EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells |
| Q38778609 | Effect of interleukin-1β and tumor necrosis factor α gene silencing on mouse gastric cancer cell proliferation and migration |
| Q34516142 | Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression. |
| Q37806003 | Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition |
| Q30418853 | Engulfment protein GULP is regulator of transforming growth factor-β response in ovarian cells |
| Q24540358 | Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. |
| Q33886142 | Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity |
| Q28081012 | Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression |
| Q38166350 | Epithelial-mesenchymal Transition and Cell Invasion |
| Q26859804 | Epithelial-mesenchymal plasticity in carcinoma metastasis |
| Q36857749 | Epithelial-mesenchymal transition and colorectal cancer: gaining insights into tumor progression using LIM 1863 cells |
| Q37620379 | Epithelial-mesenchymal transition in development and cancer |
| Q39085731 | Epithelial-mesenchymal transition in tumor metastasis |
| Q34541763 | Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel. |
| Q89883642 | Epstein-Barr Virus-Encoded Products Promote Circulating Tumor Cell Generation: A Novel Mechanism of Nasopharyngeal Carcinoma Metastasis |
| Q64080378 | Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer |
| Q37896073 | Exploring anti-TGF-β therapies in cancer and fibrosis. |
| Q42447077 | Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis. |
| Q40729379 | Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells |
| Q36785933 | FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer |
| Q55001270 | FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma. |
| Q35154337 | FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer |
| Q39618089 | Flavonoids inhibit angiogenic cytokine production by human glioma cells. |
| Q47592144 | Flt-1-Dependent Survival Characterizes the Epithelial-Mesenchymal Transition of Colonic Organoids |
| Q74298040 | Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4 |
| Q92123237 | Furin inhibition prevents hypoxic and TGFβ-mediated blood-brain barrier disruption |
| Q35119392 | Genealogy, expression, and cellular function of transforming growth factor-β |
| Q37025050 | HMGA2 is a driver of tumor metastasis. |
| Q26768428 | Homeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer Progression |
| Q37733000 | HoxB9 promotes the migration and invasion via TGF-β1/Smad2/Slug signaling pathway in oral squamous cell carcinoma |
| Q40714989 | Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells |
| Q24642963 | IKKalpha, a critical regulator of epidermal differentiation and a suppressor of skin cancer |
| Q34165529 | Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer |
| Q38986637 | Implication of Smad2 and Smad3 in transforming growth factor-β-induced posterior capsular opacification of human lens epithelial cells |
| Q47726461 | In Vivo Double Targeting of C26 Colon Carcinoma Cells and Microenvironmental Protumor Processes Using Liposomal Simvastatin |
| Q36369794 | In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice |
| Q37061943 | Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1 |
| Q33885387 | Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis |
| Q34971654 | Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappaB, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteob |
| Q39530141 | Inducible expression of TGFβ, snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model |
| Q24794867 | Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro |
| Q53390051 | Induction of cyclooxygenase-2 and invasiveness by transforming growth factor-beta(1) in immortalized mouse colonocytes expressing oncogenic Ras. |
| Q36292019 | Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment |
| Q40128542 | Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model |
| Q46252637 | Inhibition of BAMBI reduces the viability and motility of colon cancer via activating TGF-β/Smad pathway in vitro and in vivo |
| Q24671742 | Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA |
| Q36381496 | Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines |
| Q34999819 | Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progression |
| Q40833406 | Invasion and metastasis of a mammary tumor involves TGF-beta signaling |
| Q24806331 | Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition |
| Q79077062 | Involvement of TGF-beta(s)/T(beta)Rs system in tumor progression of murine mammary adenocarcinomas |
| Q40725068 | Involvement of cell-cell interactions in the rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-beta 1. |
| Q24685810 | Ionizing radiation induces heritable disruption of epithelial cell interactions |
| Q38503037 | Iron and colorectal cancer: evidence from in vitro and animal studies |
| Q40229029 | JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes |
| Q34478868 | KLF4, p21 and context-dependent opposing forces in cancer |
| Q35747946 | Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation |
| Q43148137 | Liver stem cells and molecular signaling pathways in hepatocellular carcinoma |
| Q55065930 | LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling. |
| Q30482281 | Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia |
| Q38465907 | Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas |
| Q24300340 | Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression |
| Q40089245 | Mammary epithelial cells treated concurrently with TGF-alpha and TGF-beta exhibit enhanced proliferation and death |
| Q50922670 | Manifestation of osteoblastic phenotypes in the sarcomatous component of epithelial carcinoma and sarcomatoid carcinoma. |
| Q35185712 | Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling. |
| Q34635877 | Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation |
| Q43859650 | Meeting report: signaling schemes for TGF-beta |
| Q36523877 | Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1. |
| Q54297451 | Metastasis is driven by sequential elevation of H-ras and Smad2 levels. |
| Q28394526 | Metastasis suppressor genes at the interface between the environment and tumor cell growth |
| Q30488255 | Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model |
| Q37731180 | MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications |
| Q52581027 | Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. |
| Q35620884 | Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. |
| Q36889966 | Molecular mechanisms of alcohol-mediated carcinogenesis |
| Q33909842 | Molecular mechanisms of osteolytic bone metastases |
| Q37588322 | Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts |
| Q91711304 | Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers |
| Q37286365 | NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression |
| Q50686466 | Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I. |
| Q33889211 | OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis. |
| Q36947046 | Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition. |
| Q40715312 | Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway |
| Q34126792 | Oncogenic resistance to growth-limiting conditions |
| Q37071457 | Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation |
| Q40788383 | Overexpression of matrix metalloproteinase-2 mediates phenotypic transformation of lens epithelial cells |
| Q30536377 | PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells |
| Q38357026 | Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFB1. |
| Q36014897 | Paracrine and endocrine effects of adipose tissue on cancer development and progression |
| Q36921222 | Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations |
| Q38588910 | Perioperative propofol-paravertebral anesthesia decreases the metastasis and progression of breast cancer |
| Q35745534 | Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites |
| Q40355113 | Pinocembrin suppresses TGF-β1-induced epithelial-mesenchymal transition and metastasis of human Y-79 retinoblastoma cells through inactivating αvβ3 integrin/FAK/p38α signaling pathway |
| Q28535093 | Platelet P2Y12 is involved in murine pulmonary metastasis |
| Q38584175 | Platelets in cancer metastasis: To help the "villain" to do evil |
| Q92715556 | Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway |
| Q53677089 | Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer. |
| Q51174218 | Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor. |
| Q27340972 | Py2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivo |
| Q28250360 | RAS oncogenes: weaving a tumorigenic web |
| Q40444996 | Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells |
| Q40757186 | Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways |
| Q55013837 | Ras enhances TGF-β signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1. |
| Q34623170 | Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transition |
| Q35931375 | Regulation of Epithelial-Mesenchymal Transition by Transmission of Mechanical Stress through Epithelial Tissues |
| Q39261789 | Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis |
| Q34963434 | Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo |
| Q39921205 | Restoring TGFbeta function in microsatellite unstable (MSI-H) colorectal cancer reduces tumourigenicity but increases metastasis formation. |
| Q26771696 | Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions |
| Q48010288 | Role of the extracellular matrix in cancer-associated epithelial to mesenchymal transition phenomenon |
| Q35170428 | Role of tissue stroma in cancer cell invasion |
| Q34136011 | Role of transforming growth factor beta in cancer |
| Q92596369 | Roles of Myosin-Mediated Membrane Trafficking in TGF-β Signaling |
| Q36921552 | Roles of Smad3 in TGF-beta signaling during carcinogenesis |
| Q24339520 | SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities |
| Q36105385 | Selective aryl hydrocarbon receptor modulator-mediated repression of CD55 expression induced by cytokine exposure |
| Q36284517 | Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells |
| Q26864979 | Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition |
| Q40101939 | Signaling pathways regulating TC21-induced tumorigenesis |
| Q38785742 | Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression |
| Q40495259 | Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells |
| Q39750283 | Smad signaling is required to maintain epigenetic silencing during breast cancer progression. |
| Q37603444 | Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth |
| Q30476201 | Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses |
| Q74688277 | Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells |
| Q52007365 | Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta. |
| Q36857815 | Smad4-independent TGF-beta signaling in tumor cell migration |
| Q38345085 | Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta |
| Q24309031 | Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion |
| Q38014989 | Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily. |
| Q34414642 | Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis |
| Q47101209 | Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer |
| Q36937053 | Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers |
| Q26738551 | Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer |
| Q34639841 | TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis |
| Q40320864 | TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling |
| Q34136526 | TGF-beta and colorectal carcinogenesis |
| Q29616456 | TGF-beta and epithelial-to-mesenchymal transitions |
| Q39957865 | TGF-beta has paradoxical and context dependent effects on proliferation and anoikis in human colorectal cancer cell lines |
| Q34421804 | TGF-beta signaling in cancer--a double-edged sword |
| Q29615427 | TGF-beta signaling in tumor suppression and cancer progression |
| Q36001319 | TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. |
| Q40727835 | TGF-beta(1) and Smad4 overexpression induce a less invasive phenotype in highly invasive spindle carcinoma cells |
| Q29619820 | TGF-beta-induced epithelial to mesenchymal transition |
| Q37693902 | TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression |
| Q46183468 | TGF-β inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1 |
| Q30597668 | TGF-β regulates LARG and GEF-H1 during EMT to affect stiffening response to force and cell invasion. |
| Q37492534 | TGF-β regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes |
| Q92377249 | TGF-β signaling promotes tube-structure-forming growth in pancreatic duct adenocarcinoma |
| Q37641591 | TGF-β1 stimulates migration of type II endometrial cancer cells by down-regulating PTEN via activation of SMAD and ERK1/2 signaling pathways. |
| Q39103885 | TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion |
| Q45364293 | TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence |
| Q35589431 | TGFbeta induces morphological and molecular changes similar to human anterior subcapsular cataract |
| Q28142605 | TGFbeta signaling in growth control, cancer, and heritable disorders |
| Q33980127 | TGFbeta signaling supports survival and metastasis of endometrial cancer cells. |
| Q36619111 | TGFbeta-mediated signaling and transcriptional regulation in pancreatic development and cancer. |
| Q35079908 | TGFbeta-regulated transcriptional mechanisms in cancer |
| Q39903519 | TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch |
| Q28589847 | TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development |
| Q28083107 | TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis |
| Q48577765 | TGFβ can stimulate the p(38)/β-catenin/PPARγ signaling pathway to promote the EMT, invasion and migration of non-small cell lung cancer (H460 cells). |
| Q33648775 | TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells |
| Q46256864 | Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity |
| Q28067219 | Targeting microenvironment in cancer therapeutics |
| Q35042977 | Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer |
| Q35169582 | Targeting the TGF beta signaling network in human neoplasia |
| Q40717397 | Targets of transcriptional regulation by transforming growth factor-beta: expression profile analysis using oligonucleotide arrays |
| Q41711662 | Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells. |
| Q34356297 | Tgf-beta signaling pathway in lung adenocarcinoma invasion. |
| Q59355701 | The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers |
| Q34278562 | The Kindler syndrome protein is regulated by transforming growth factor-beta and involved in integrin-mediated adhesion. |
| Q42009631 | The Misregulation of Cell Adhesion Components during Tumorigenesis: Overview and Commentary |
| Q33784365 | The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression |
| Q36522719 | The Role of TGFβ Signaling in Squamous Cell Cancer: Lessons from Mouse Models |
| Q57816901 | The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity |
| Q37328463 | The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling |
| Q33800658 | The Smads. |
| Q28207920 | The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation |
| Q36429644 | The alphaVbeta6 integrin as a novel molecular target for colorectal cancer |
| Q44159142 | The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT. |
| Q24652992 | The basics of epithelial-mesenchymal transition |
| Q37780777 | The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy |
| Q34295021 | The early steps of neural crest development |
| Q34310378 | The epigenetics of epithelial-mesenchymal plasticity in cancer |
| Q36547739 | The evolving portrait of cancer metastasis. |
| Q34989790 | The genetic pathogenesis of colorectal cancer |
| Q34483637 | The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway |
| Q39372971 | The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). |
| Q33860861 | The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter |
| Q28254798 | The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it |
| Q24801456 | The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. |
| Q40626766 | The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. |
| Q36241260 | The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer |
| Q35969342 | The role of TGF-beta in epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II). |
| Q26997815 | The role of the myofibroblast in tumor stroma remodeling |
| Q36677504 | The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis |
| Q28216843 | The snail superfamily of zinc-finger transcription factors |
| Q33607396 | The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma. |
| Q37157489 | The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha |
| Q36964339 | The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway |
| Q37112272 | The type I TGF-beta receptor is covalently modified and regulated by sumoylation |
| Q21195231 | The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta |
| Q73855680 | There is no increase in frequency of somatic mutations in metastases compared with primary colorectal carcinomas with microsatellite instability |
| Q33806990 | Tissue geometry patterns epithelial-mesenchymal transition via intercellular mechanotransduction |
| Q35591715 | Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis |
| Q33731789 | Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma |
| Q36279142 | Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma |
| Q36897816 | Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells |
| Q43850094 | Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1. |
| Q33948465 | Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1 |
| Q40660373 | Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. |
| Q39939459 | Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth |
| Q24793229 | Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models |
| Q24793265 | Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer |
| Q24793319 | Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta |
| Q45074420 | Transforming growth factor-beta facilitates breast carcinoma metastasis by promoting tumor cell survival |
| Q37219226 | Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer? |
| Q42826872 | Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase- and matrix metalloproteinase-dependent pathway. |
| Q74615795 | Transforming growth factor-beta-induced upregulation of transforming growth factor-beta receptor expression in pancreatic regeneration |
| Q44508741 | Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways |
| Q24600173 | Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism |
| Q35747461 | Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin |
| Q38315881 | Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region |
| Q39447639 | Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma |
| Q39346505 | Transforming growth factor-β: A therapeutic target for cancer |
| Q24791032 | Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system. |
| Q73734549 | Translation control: bridging the gap between genomics and proteomics? |
| Q41093090 | TrkC promotes colorectal cancer growth and metastasis |
| Q45248957 | Tumor cell invasiveness correlates with changes in integrin expression and localization |
| Q35153367 | Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids |
| Q36516410 | Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer |
| Q40469680 | Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. |
| Q44792812 | Visualization of the post-Golgi vesicle-mediated transportation of TGF-β receptor II by quasi-TIRFM. |
Search more.